IP Library Granted Patent US 7,150,976
Granted Patent B2
US 7,150,976 · App. 10/398,920 · Granted Dec 19, 2006

Regulation of human serine-threonine protein kinase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,150,976
App. No.
10/398,920
Granted
Dec 19, 2006
Kind
B2
Abstract

Reagents which regulate human serine-threonine protein kinase and reagents which bind to human serine-threonine protein kinase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, CNS disorders, diabetes, and COPD.

Claims (6)

1. A method of screening for candidate therapeutic agents, comprising the steps of:

contacting a protein comprising the amino acid sequence of SEQ ID NO: 2 or the amino acid sequence of SEQ ID NO: 17 with a test compound;

assaying for binding between the protein and the test compound; and

identifying a test compound that binds to the protein as a candidate therapeutic agent that may be useful for treating colon cancer.

2. The method of claim 1 wherein either the test compound or the protein comprises a detectable label.

3. The method of claim 1 wherein either the test compound or the protein is bound to a solid support.

Assignments (3)
MERGER Recorded Feb 19, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022277/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2006
From: BAYER AKTIENGESELLSCHAFT
To: BAYER HEALTHCARE AG
Reel/Frame 017886/0004 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2003
From: ZHU, ZHIMIN
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 014298/0859 →